Analysis Novo Nordisk’s Pipeline Hope Meets Commercial Reality: India Clearance and CVS Reversal Collide
Novo Nordisk enters a critical week with the stock caught between two opposing forces: a fresh regulatory win in India that opens Wegovy to a younger patient group, and the...